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Introduction
Protein 4.1 is a major component of the red cell skeleton that strengthens the spectrin-actin lattice and contributes to the skeleton anchoring to the membrane via the cytoplasmic domains of transmembrane proteins ( 1, 2) . Functional studies have established that the binding to the spectrin-actin complex of protein 4.1 resides in a 10-kD internal domain (3, 4) (see Fig. 1 ).
The erythroid form of protein 4.1 is now known to be a F. Lorenzo and N. Dalla Venezia contributed equally to this study.
F. Lorenzo's present address is Gdnethon, 1 member of a complex protein family that arises from a single gene by alternative mRNA splicing (5, 6) . One particular splicing event involves a 21-amino acid sequence motif, also called Motif I, the retention of which at the late stage of red cell development was found to be critical for protein 4.1 binding activity (7) (8) (9) (10) (11) (12) ) (see Fig. 1 ). 4.1(-)HE designates a variety of hereditary elliptocytosis (HE)' associated with a reduction or a virtual absence of protein 4.1 in the membrane, reflecting a heterozygous or a homozygous state, respectively (for review see reference 2).
Starting from previous studies on 4.1 (-)HE ( 13 ), we delineated a small genetic isolate for a novel protein 4.1 variant, protein 4.1 Aravis. This variant lacked one lysine residue at position 447 (or 448), in the 3' portion of the 10-kD domain. Various assays using recombinant 10-kD domain established that the single lysine deletion abolishes the binding to spectrin, to the spectrin-actin complex or to the red cell membrane. These data, together with the genetic analysis of protein 4.1 Aravis carriers, suggest the lysine deletion to be the molecular basis of protein 4.1 deficiency.
Methods
Epidemiological, clinical, and routine biochemical studies. This investigation was initiated from a set of nine families with symptomless 4.1 (-)HE recruited on a random basis (13) . These families failed to form a homogeneous group as shown by Northern blot analysis (13) and/or genealogical studies (14) . Only four families, BE, BG, DU, and GR, were closely related. They resided in or originated from two valleys in the Aravis mountains (French Northern Alps). In view of a possible founder effect, we assumed that the present-day inhabitants of this area, being of local descent for most of them, would exhibit an unusually high incidence of 4.1 (-)HE. An epidemiological survey (blood smears) of school children showed that 6 children out of 155 (3.87%) presented with HE ( 14) . To establish the 4. 1 (-) nature of HE, we assayed protein 4.1 (SDS-PAGE) in the parents displaying elliptocytosis, the inheritance pattern of elliptocytosis being dominant. Five additional 4.1 (-)HE families were identified: BG2, BG3, GO, GP, and VD (see Fig. 2 ). They proved to be related to one another as well as to the four above families through a complex pattern of endogamy (14) . Retrospectively, the mutation (described below) was recognized in all the kindreds from the cluster which could be reinvestigated in this respect. Taken together, a small genetic isolate for a particular 4.1 (-) allele has been outlined.
Furthermore, we screened the mutation (defined below) in a number of other 4.1 (-) HE families. Some were from the French Northern Alps, but failed to belong to the isolate; i.e., families BU, CA, LA, and PE (13) (13, 17) .
Studies on cDNA and genomic DNA. Total reticulocyte mRNA was prepared from peripheral blood as polysomal precipitates. 2 jig of RNA were reverse transcribed and PCR amplified as previously described or referred to (18) , using sequence specific primers (Table I and Fig. 1 ).
In general, 30 PCR products were analyzed on 3% Nusieve GTG gels (FMC BioProducts, Rockland, ME) and cloned into EcoRI-digested M13 mp 18 Vector (Pharmacia, Uppsala, Sweden). DNA sequencing was performed using specific primers (Table I and Fig. 1 ) or the M13 sequencing primer -40 (USB, Cleveland, OH). PCR-amplified cDNA was also digested with XmnI, or AlwNI (New England Biolabs, Beverly, MA), and analyzed on 3.5% Nusieve GTG gels (FMC BioProducts).
Genomic DNA was prepared from peripheral blood leukocytes according to standard procedures (including a ribonuclease A treatment of the leukocytes nuclei), or using the InstaGene Purification Matrix (Bio-Rad, Richmond, CA). 200 ng were PCR amplified as described above. The products were submitted to XmnI mapping and analyzed on 6% Nusieve GTG gels (FMC BioProducts).
Purification of spectrin and protein 4.1. Preparation of red cell membranes was carried out as described before (17) . Crude spectrin extract was obtained by washing the ghosts twice in 1 mM ,B-mercaptoethanol, 1 mM EDTA, 0.3 mM PMSF, pH 9.5 (with NH40H), and incubation for 30 min at 37°C (19) . Under these conditions, the spectrin extract was devoid of protein 4.1 as assessed by Western blot. Protein 4.1 was extracted from spectrin-depleted vesicles with 1 M KCl (20) and then purified by selective interaction with inositol hexaphosphate (21) . Spectrin and protein 4.1 were dialyzed overnight against buffer A (130 mM KCl, 20 mM NaCl, 0.1 mM EGTA, 10 mM Tris, pH 7.4).
Their concentration was estimated by Bradford assay (22) .
Plasmid constructs and protein expression of the 10-kD domain. Primers X to XII (Table I and Fig. 1 ) were used to specifically amplify the 10-kD domain of protein 4.1 from a HE heterozygote. Four different fragments were generated by PCR. They will be referred to as 1OK( + I), 1OK(-I), 1OK*(+I), and 10K*(-I) (*HE allele), whether they contain (+1) or lack (-I) Motif I sequence. The fragments were digested with BamHI and EcoRI, and cloned into pGEX-3X expression vector (Pharmacia). The constructs were fully sequenced to ascertain the absence of an additional sequence change that would result from the PCR experiments.
The four products were expressed in E. coli HB101 (GIBCO BRL, Gaithersburg, MD), as glutathione-S-transferase (GST) fusion proteins (23) . Overnight cultures were diluted to 1:50 with Luria broth medium and grown to an ODww.,,, of 0.6. Isopropylthiogalactopyranoside was added up to 0.1 mM and bacteria were grown for an additional 2 h.
Cells were harvested and resuspended in 1:50 culture volume of a lysis buffer containing 50 mM Tris, 50 mM NaCl, 1 mM EDTA, 0.15 mM PMSF, pH 8.0 at 0°C. They were treated for 15 min at 0°C with 2 mg/ ml lysozyme and for an additional 15 min with 0.2 mg/ml deoxyribonuclease I, 7 mM MgCl2, 1% Triton X-100, 1 mM PMSF. The GSTfusion proteins were purified from the lysates as previously described (23) using glutathione-Sepharose 4B beads (Pharmacia). Protein concentration was determined using the method of Bradford (22) . The purity of the fusion proteins was assessed by 12 DlT). Each sample was then applied to a 3.5% polyacrylamide nondenaturing gel and electrophoresed as described before (24) .
G-actin (Sigma Chemical Co., St. Louis, MO) was polymerized at a concentration of 1 mg/ml in 100 mM KCl, 2 mM MgC12, 0.2 mM ATP, 0.2 mM CaCl2, and 10 mM DTI at 25°C for 1 h before use. Binding assays were performed as previously described (4) (13) .
Two pairs of primers, I/HI and HI/IV ( Fig. 1 ; Table I ) were designed to amplify two overlapping regions of the mRNA encompassing the entire erythroid coding sequence. The resulting PCR products obtained in family GP were cloned and sequenced. No sequence change was found in the 5' half of the cDNA. On the contrary, the 3' region revealed a AAA codon deletion in 7 clones out of 12 (Fig. 3) . This change results in the loss of a lysine residue from the Lys447-Lys448 tandem.
(Amino acids were numbered according to Conboy et al. (6) , and starting from the downstream AUG. However, the 57-bp motif, absent from the erythroid isoform, was not taken into account.) The abnormal allele was designated allele 4.1 Aravis.
The nucleotide sequence change generates an XmnI restriction site. Digestion of the PCR product (primers III/ VI) yielded two fragments of 625 and 75 bp instead of a 700-bp fragment (data not shown).
Protein 4.1 mRNA was also amplified using primers I and VI. The resulting 1536-bp fragment was digested with XmnI. Fragments of 1,536 bp (normal allele) and of 1,461 and 75 bp (mutated allele) were obtained (data not shown). These findings ruled out the presence of an additional alteration that would, in particular, have prevented cDNA priming with primer I.
Nucleotide sequencing revealed a GGA GCA GCT sequence (-Gly-Ala-Ala-) together with the expected sequence GGA GCA GCA GCT (Gly-Ala-Ala-Ala; positions 336-339) (6) (data not shown). The We tested the lysine codon deletion at the genomic level using XmnI digestion of PCR products. Primers V and VI designed within the same exon were used for PCR amplification (Fig. 3 ).
This AAA deletion was screened at the gene level in at least one 4.1 (-)HE member from each of the 6 other families belonging to the isolate (Fig. 2) . It domains were assayed for their binding to spectrin in a binary complex. Increasing amounts of GST-1OK(+ I) construct were incubated with 10 Mg of crude spectrin and subsequently electrophoresed on nondenaturing polyacrylamide gel (Fig. 4) . Only native free spectrin, mainly dimers and tetramers, would migrate whereas protein 4.1 -spectrin complexes remain trapped in the wells (24) (Fig. 4) . The amount of free spectrin decreased in proportion as the quantity of GST-1OK( + I) domain increased. The minimum concentration of GST-1OK(+I) domain, required to complex all the spectrin molecules, was 1.8 Mg. Constructs lacking Motif I (GST-1OK[-I] and GST-1OK*[-I]) did not bind to spectrin (Fig. 4) , even at high concentrations (up to 5 Mg). These findings were expected knowing that Motif I sequence is essential to the binding (8, 11, 12) . Remarkably, no binding was observed with GST-1OK*( + I) construct which carries the lysine deletion (Fig. 4) . Both GST alone and heatdenatured GST-1OK(+I) were unable to bind spectrin (not shown). These experiments suggested that the lysine deletion alters a sequence critical for the binary complex formation.
Ternary complex formation occurs when protein 4.1, or its chymotryptic 10-kD fragment, are added to spectrin and F-actin (4). A second binding assay, based on differential sedimentation, was performed with GST-IOK(+ I), GST-1OK( -I), and GST-1OK*(+I) constructs (Fig. 4) . As expected, GST-1OK(+ I) was the only product allowing the sedimentation of spectrin as a ternary complex. Binding experiments performed with GST-1OK( -I) or GST-IOK*( + I) domains generated the same pattern as with several negative controls (spectrin + actin, spectrin + GST-1OK(+I), or spectrin + actin + denatured GST-1OK( + I)).
Competition assays of the GST-1OK( +I) domain and native protein 4.1 for the binding to spectrin-actin complex established that the construct mimics the native protein (Fig. 5) ; half of the GST-1OK(+I) domain was displaced by 0.5 mole equivalents of protein 4.1, and up to 90% of the construct was displaced by a 5 mole excess of protein 4.1. These results are quite similar to previous data using 10-kD domain without GST (12) . Pellets were resolved by SDS-PAGE. In contrast with binding conditions presented on Fig. 4 (right) , a limiting amount of spectrin has been used.
To ascertain the binding defect of protein 4.1 Aravis to spectrin-actin complex in situ, incorporation of the GSTlOK*(+ I) construct into red cell membranes was assayed. Increasing amounts of GST-1OK( + I) and GST-lOK(-I) constructs were used as positive and negative controls, respectively. The GST-1OK *( + I) did not associate to the red cell membranes (Fig. 6 ).
Discussion
After the recent description of allele 4.1 Madrid ( 16), harboring a point mutation in the downstream initiation codon, allele 4.1 Aravis is the second allele responsible of 4.1 (-)HE to be defined at the gene level. It is likely that most mutations responsible for 4.1 (-) HE are private, being restricted to single families. The recurrence of allele 4.1 Aravis is the consequence of the endogamic structure of a community living in an isolated area ( 14) .
The normal quality and quantity of total protein 4.1 mRNA ruled out a major transcriptional or posttranscriptional defect. We therefore hypothesized that protein 4.1 Aravis was synthesized but was unable to bind to the membrane. The lack of binding of the construct GST-1OK*(+I) to spectrin, the spectrin-actin complex and red cell membranes strongly supported this assumption. The absence of one lysine from the Lys447-Lys448 tandem produces as drastic effects on the binding to the spectrin-actin complex as the lack of Motif I (construct GST-1OK[-I]). Therefore, the 21-amino acid motif (position 407 to 427) is not the only part of the 10-kD domain that is critical for binding to the spectrin-actin complex. Position 447 (or 448) also appears to be crucial in this respect. It belongs to an a helix (26) which may be disrupted by the absence of one lysine residue from the Lys447-Lys448 tandem.
It is noteworthy that this amino acid sequence is a highly conserved region among mammals (100% sequence homology between human, mouse, and dog) (27, 28) , avians (95% sequence homology between human and chicken) (29), and amphibians (30) ; there is perfect conservation of the Lys447-Lys448 tandem among these species.
Unbound protein 4.1 Aravis must be rapidly degraded, even though Western blots did not evidence low molecular weight species in the membrane (13) . The possibility remains that a small amount of protein 4.1 Aravis is present in the membrane. Subtle differences probably exist between 4.1(-)HE alleles but they stand below the sensitivity threshold of SDS-PAGE analysis. In the present case, the absence of a single amino acid would result in the complete ( 400 MI of red cell membranes were incubated with increasing amounts of GST-1OK(+I) (5), GST-IOK(-I) (n), and GST-1OK*(+I) (n).
Samples were electrophoresed and incorporation of each construct was evaluated by scanning of the gel, using G3PDH as reference. protein 4.1, whereas a protein 4.1 variant, missing the 63 and 177 nucleotide motifs (31), was still able to be incorporated in the membrane (31 ) . However, there is some evidence (31 ) that the amount of this truncated protein 4.1 was low, manifesting in a consistent fashion the binding defect.
Binding of protein 4.1 to nonspectrin proteins has been evidenced. Indeed, it is now established that -20% of protein 4.1 output contributes to the skeleton anchoring to the membrane, probably through an interaction of the 30-kD domain with glycophorin C and p55 (32) (33) (34) . Protein 4.1 Aravis contains an intact 30-kD domain; therefore, one may assume that binding to nonspectrin proteins must be unaltered in this particular case. In fact, quantitative analysis, recently reported (34), has shown a slight p55 decrease in 4.1 (-)HE heterozygotes, including patients here found to carry 4.1 Aravis allele. To reconcile these conflicting findings, we may speculate that binding to the spectrin-actin complex is a prerequisite for binding to glycophorin C and p55. Alternatively, the lysine deletion may generate a secondary conformational change that also prevents an efficient binding of the 30-kD domain to p55.
In this study, we identified a genetic isolate for 4.1 (-)HE. Based on preliminary data, we have first ruled out a quantitative defect or a large deletion at the mRNA level. Subsequently, a AAA single codon deletion, abolishing a lysine residue within the 10-kD domain, was consistently found in the 4.1 HE patients, thus defining allele 4.1 Aravis. Using various binding assays, we finally established that recombinant 10-kD domain carrying this change was unable to bind to the spectrin-actin complex.
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